Results of an international Intregroup randomized phase III trial of pazopanib versus placebo (AGO-OVAR16). Subgroup Analysis of toxicity and clinical outcome in the Asian and Non-Asian population

被引：0

作者：

Sehouli, J. ^{[1
]}

Harter, P. ^{[2
]}

Wimberger, P. ^{[3
]}

Rau, J. ^{[4
]}

Baumann, K. ^{[5
]}

Kurzeder, C. ^{[6
]}

Canzler, U. ^{[7
]}

Meier, W. ^{[8
]}

Hanker, L. C. ^{[9
]}

Mahner, S. ^{[10
]}

Krabisch, P. ^{[11
]}

Reiter, W. W. ^{[12
]}

Aminossadati, B. ^{[4
]}

du Bois, A. ^{[13
]}

机构：

[1] Charite, Campus Virchow Klinikum, Frauenklin, D-13353 Berlin, Germany

[2] Dr Horst Schmidt Klin, Klin Gynakol & Gynakol Onkol, Wiesbaden, Germany

[3] Univ Klinikum Essen, Klin Frauenheilkunde & Geburtshilfe, Essen, Germany

[4] KKS, Marburg, Germany

[5] Univ Klinikum Giessen & Marburg, Marburg, Germany

[6] Univ Ulm Klinikum, Univ Fraeunklin, Ulm, Germany

[7] Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Dresden, Germany

[8] Evangel Krankenhaus, Fraeunklin, Dusseldorf, Germany

[9] Klinikum JW Goethe Univ, Zentrum Frauenheilkunde & Geburtshilfe, Frankfurt, Germany

[10] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Gynakol, Hamburg, Germany

[11] Klinikum Chemnitz, Frauenklin, Chemnitz, Germany

[12] Schwerpunkt Praxis, Viersen, Germany

[13] Kliniken Essen Mitte, Klin Gynakol Onkol, Essen, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 75

页数：1

共 21 条